National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Amendment (No. 2) Determination 2022 (Cth)

PB 42 of 2022

National Health (Pharmaceutical Benefits)

(Pharmacist Substitution of Medicines without

Prescription during Shortages) Amendment (No. 2) Determination 2022

I, Nikolai Tsyganov, as delegate of the Minister for Health and Aged Care, make the following determination.

Dated         18 May 2022

Nikolai Tsyganov

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Contents

1. Name ........................................................................................................................... 1

1. Commencement .......................................................................................................... 1

1. Authority ..................................................................................................................... 1

1. Schedules .................................................................................................................... 1

Schedule 1—Amendments

National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines

2

without Prescription during Shortages) Determination 2021

2

1  Name

(1)    This instrument is the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Amendment (No. 2) Determination 2022.

(2)    This instrument may also be cited as PB 42 of 2022.

2  Commencement

(1)    Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	20 May 2022.	20 May 2022.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)    Any information in column 3 of the table is not part of this instrument.

Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 89A(3) of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1  Amendments

Schedule 1—Amendments

National Health (Pharmaceutical Benefits) (Pharmacist Substitution of

Medicines without Prescription during Shortages) Determination 2021

1  Subsection 5(8), omit:

1	Listed drug: Tocilizumab	Listed drug: Tocilizumab
Form: Injection 162 mg in 0.9 mL single use pre‑filled syringe	Form: Injection 162 mg in 0.9 mL single use pre‑filled pen
Manner of administration: Injection	Manner of administration: Injection
Brand: Actemra Subcutaneous Injection	Brand: Actemra ACTPen
2	Listed drug: Tocilizumab	Listed drug: Tocilizumab
Form: Injection 162 mg in 0.9 mL single use pre‑filled pen	Form: Injection 162 mg in 0.9 mL single use pre‑filled syringe
Manner of administration: Injection	Manner of administration: Injection
Brand: Actemra ACTPen	Brand: Actemra Subcutaneous Injection
3	Listed drug: Estradiol	Listed drug: Estradiol
Form: Tablet containing estradiol valerate 1 mg	Form: Tablet 2 mg
Manner of administration: Oral	Manner of administration: Oral
Brand: Progynova	Brand: Zumenon
4	Listed drug: Estradiol	Listed drug: Estradiol
Form: Tablet containing estradiol valerate 2 mg	Form: Tablet 2 mg
Manner of administration: Oral	Manner of administration: Oral
Brand: Progynova	Brand: Zumenon